This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Novartis Ag, Sandoz Ag. Active years: 2008-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- L'Ametlla del Vallès/ Barcelona, ES (2008)
- Barcelona, ES (2015)
Company Filing History:
Years Active: 2008-2015
Title: Albert Codony: Innovator in Pharmaceutical Chemistry
Introduction
Albert Codony is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antibacterial agents. With a total of 2 patents, Codony's work has had a meaningful impact on medical treatments.
Latest Patents
Codony's latest patents include a process for the preparation of 9-deoxo-9a-homoerythromycin A. This invention concerns a process for the preparation of a key intermediate compound that is essential in synthesizing antibacterial agents of the triamilide class, such as Tulathromycin. This compound is particularly useful in treating bacterial and protozoan infections. Another significant patent involves derivatives of azithromycin, which includes processes for their manufacture and pharmaceutical compositions, preferably in conjunction with azithromycin.
Career Highlights
Throughout his career, Albert Codony has worked with prominent companies in the pharmaceutical industry, including Sandoz AG and Novartis AG. His expertise in the field has allowed him to contribute to various innovative projects that enhance the effectiveness of antibacterial treatments.
Collaborations
Codony has collaborated with notable coworkers such as Rafael Garcia and José Diago. These partnerships have further enriched his research and development efforts in pharmaceutical innovations.
Conclusion
Albert Codony's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

